Related Experiment Video
Updated: Aug 22, 2025
06:07
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.7K
Inhibitors of DNA Methylation
Marie Lopez1, Julie Gilbert1, Jean Contreras2,3
1Institut des Biomolécules Max Mousseron (IBMM), CNRS, Université de Montpellier, ENSCM UMR 5247, Montpellier, France.
Advances in Experimental Medicine and Biology
|November 9, 2022
Summary
DNA methylation is crucial for biological processes but is altered in diseases. Inhibitors of DNA methyltransferases (DNMTs) offer therapeutic potential for various conditions and advanced bioengineering applications.
Area of Science:
- Epigenetics and molecular biology, focusing on DNA methylation dynamics.
Background:
- DNA methylation is integral to biological functions and its dysregulation is implicated in human diseases.
- Modulating DNA methyltransferases (DNMTs) offers a strategy to correct aberrant DNA methylation patterns in disease states.
Approach:
- This chapter reviews DNA methyltransferase inhibitors (DNMTi) as therapeutic agents and bioengineering tools.
- Examples of DNMTi applications in oncology, cardiovascular, neurological, and infectious diseases are discussed.
- Novel strategies, including targeting methyl-binding proteins and combination therapies (e.g., DNMT and HDAC inhibitors), are presented to enhance efficacy and reduce side effects.
Key Points:
- DNMT inhibitors represent a promising therapeutic avenue for diverse diseases.
- Bioengineering applications leverage DNMTi for precise control of epigenetic modifications.
- Next-generation strategies aim to overcome limitations of current DNMT inhibitors through targeted approaches.
Conclusions:
- Targeting DNA methylation pathways, particularly DNMTs, holds significant therapeutic and biotechnological potential.
- Developing novel DNMT inhibitors and combination therapies can improve treatment outcomes and minimize adverse effects.
- Future research directions focus on innovative strategies for precise epigenetic modulation.
Related Concept Videos
01:52Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
01:37Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
01:17Phase II Reactions: Methylation Reactions
289
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
289
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
02:30Genomic Imprinting and Inheritance
35.0K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.0K
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K